Connect Biopharma CNTB Stock
Connect Biopharma Price Chart
Connect Biopharma CNTB Financial and Trading Overview
| Connect Biopharma stock price | 1.72 USD |
| Previous Close | 1.02 USD |
| Open | 1.03 USD |
| Bid | 0 USD x 2200 |
| Ask | 0 USD x 800 |
| Day's Range | 0.95 - 1.04 USD |
| 52 Week Range | 0.62 - 2.08 USD |
| Volume | 83.3K USD |
| Avg. Volume | 651.24K USD |
| Market Cap | 55.59M USD |
| Beta (5Y Monthly) | -0.515452 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.53 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 6.3 USD |
CNTB Valuation Measures
| Enterprise Value | -1003284864 USD |
| Trailing P/E | N/A |
| Forward P/E | -0.49029127 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.05068246 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | 1.286 |
Trading Information
Connect Biopharma Stock Price History
| Beta (5Y Monthly) | -0.515452 |
| 52-Week Change | 33.24% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 2.08 USD |
| 52 Week Low | 0.62 USD |
| 50-Day Moving Average | 1.11 USD |
| 200-Day Moving Average | 1.04 USD |
CNTB Share Statistics
| Avg. Volume (3 month) | 651.24K USD |
| Avg. Daily Volume (10-Days) | 2.05M USD |
| Shares Outstanding | 55.04M |
| Float | 18.45M |
| Short Ratio | 2.23 |
| % Held by Insiders | 39.85% |
| % Held by Institutions | 41.45% |
| Shares Short | 84.05K |
| Short % of Float | N/A |
| Short % of Shares Outstanding | 0.14% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -31.99% |
| Return on Equity (ttm) | -56.27% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -780296000 USD |
| Net Income Avi to Common (ttm) | -797054976 USD |
| Diluted EPS (ttm) | -1.96 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 1.06B USD |
| Total Cash Per Share (mrq) | 19.29 USD |
| Total Debt (mrq) | 3M USD |
| Total Debt/Equity (mrq) | 0.27 USD |
| Current Ratio (mrq) | 9.97 |
| Book Value Per Share (mrq) | 19.928 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -679665024 USD |
| Levered Free Cash Flow (ttm) | -454258624 USD |
Profile of Connect Biopharma
| Country | United States |
| State | CA |
| City | San Diego |
| Address | 12265 El Camino Real |
| ZIP | 92130 |
| Phone | (858) 727-1045 |
| Website | https://www.connectbiopharm.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 100 |
Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on developing therapies to treat T cell-driven inflammatory diseases. The company is building a pipeline of small molecules and antibodies using functional T cell assays to screen and discover potent product candidates against validated immune targets. Its lead product candidate is CBP-201, an antibody to target interleukin-4 receptor alpha in development for the treatment of atopic dermatitis (AD) and asthma. The company's product candidates also comprise CBP-307, a modulator of S1P1 T cell receptor and is in development for the treatment of ulcerative colitis; and CBP-174, a peripherally acting antagonist of histamine receptor 3 in development for the treatment of pruritus associated with skin inflammation. Connect Biopharma Holdings Limited was founded in 2012 and is headquartered in San Diego, California.
Q&A For Connect Biopharma Stock
What is a current CNTB stock price?
Connect Biopharma CNTB stock price today per share is 1.72 USD.
How to purchase Connect Biopharma stock?
You can buy CNTB shares on the NasdaqGM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Connect Biopharma?
The stock symbol or ticker of Connect Biopharma is CNTB.
Which industry does the Connect Biopharma company belong to?
The Connect Biopharma industry is Biotechnology.
How many shares does Connect Biopharma have in circulation?
The max supply of Connect Biopharma shares is 55.07M.
What is Connect Biopharma Price to Earnings Ratio (PE Ratio)?
Connect Biopharma PE Ratio is now.
What was Connect Biopharma earnings per share over the trailing 12 months (TTM)?
Connect Biopharma EPS is -1.53 USD over the trailing 12 months.
Which sector does the Connect Biopharma company belong to?
The Connect Biopharma sector is Healthcare.
Connect Biopharma CNTB included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ Global Market Composite NQGM | 2160.36 USD — |
-2.45
|
— — | 2147.48 USD — | 2200.33 USD — | — - | — — |
| NASDAQ Biotechnology NBI | 4195.13 USD — |
-2.14
|
— — | 4174.1 USD — | 4266.29 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
| Stlmt ID NASDAQ Biotechnology NBX | 4604.4 USD — |
-2.98
|
— — | 4555.41 USD — | 4917.8 USD — | — - | — — |
- {{ link.label }} {{link}}